The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N01 | Anesthetics | |
| 3 | N01A | Anesthetics, general | |
| 4 | N01AX | Other general anesthetics | |
| 5 | N01AX14 | Esketamine |
| Active Ingredient | Description | |
|---|---|---|
| Esketamine |
Esketamine, the S-enantiomer of racemic ketamine, is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. Through NMDA receptor antagonism, esketamine produces a transient increase in glutamate release. Restoration of dopaminergic neurotransmission in brain regions involved in the reward and motivation, and decreased stimulation of brain regions involved in anhedonia, may contribute to the rapid response. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
